Determining the minimal clinically important difference for the questionnaire of olfactory disorders in people with cystic fibrosis and factors associated with improvement after highly effective modulator therapy

By sjmartinez • June 3, 2024

Miller JE, Taylor-Cousar JL, Overdevest JB, Khatiwada A, Mace JC, Alt JA, Bodner TE, Chowdhury NI, DiMango EA, Eshaghian PH, Getz AE, Gudis DA, Han EJ, Hwang PH, Keating CL, Khanwalkar A, Kimple AJ, Lee JT, Li D, Markarian K, Norris M, Nayak JV, Owens C, Patel ZM, Poch K, Schlosser RJ, Smith KA, Smith TL, Soler ZM, Suh JD, Tervo JP, Turner GA, Wang MB, Saavedra MT, Beswick DM. Determining the minimal clinically important difference for the questionnaire of olfactory disorders in people with cystic fibrosis and factors associated with improvement after highly effective modulator therapy. Int Forum Allergy Rhinol. 2024 Jun;14(6):1079-1087. doi: 10.1002/alr.23312. Epub 2023 Dec 25. PMID: 38145393.

Tags: chronic rhinosinusitis, cystic fibrosis, highly effective modulator therapy, olfaction, olfactory disorders, olfactory dysfunction, olfactory test, patient‐reported outcome measure, Publications, Pulmonary, Critical Care & Sleep Medicine, Quality of Life

Designing an Inclusive Onboarding Program for Academic Ambulatory Care Faculty

Bilek A, Rabbani A, Wampande J, Pregler J. Designing an Inclusive Onboarding Program for Academic Ambulatory Care Faculty. Cureus. 2025 Jun 4;17(6):e85356. doi: 10.7759/cureus.85356. PMID:[...]

Hospital Patient Experience Worsened With the COVID-19 Pandemic, Especially for Older Adults, and Remains Worse than Before

Beckett MK, W Cohea C, Saliba D, Cleary PD, A Giordano L, Elliott MN. Hospital Patient Experience Worsened With the COVID-19 Pandemic, Especially for Older[...]

Deep Learning Multi Modal Melanoma Detection: Algorithm Development and Validation

Vivek N, Ramesh K. Deep Learning Multi Modal Melanoma Detection: Algorithm Development and Validation. JMIR AI. 2025 Jul 5. doi: 10.2196/66561. Epub ahead of print.[...]